Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model
Open Access
- 19 May 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-10
Abstract
In this study, we used a new coating agent, that is, ultra-purified alginate gel (UPAL), for fetal liver tissue transplantation. This study aims to compare the effect of UPAL with the effect of other coating agents on improving the effect of fetal liver tissue transplantation in a liver cirrhosis rat model. Prior to the transplantation of wild-type ED14 fetal liver tissues, various coating agents were separately applied on the liver surface of rats with cirrhosis. Then, we compared the engraftment area, engraftment rate and liver function level of these rats. As a result, coating the liver surface of a cirrhosis rat with UPAL obtained the best effect in terms of engraftment area and engraftment rate of the transplanted liver tissue and in the recovery of liver function compared with control group. Therefore, UPAL coating may serve as a novel strategy for liver organoid transplantation.Keywords
Funding Information
- Japan Agency for Medical Research and Development (translational research seeds B, translational research seeds B)
This publication has 33 references indexed in Scilit:
- Repair of Rabbit Osteochondral Defects by an Acellular Technique with an Ultrapurified Alginate Gel Containing Stromal Cell-Derived Factor-1Tissue Engineering Part A, 2012
- MR imaging in liver cirrhosis: classical and new approachesInsights into Imaging, 2010
- Regulation of liver regeneration by growth factors and cytokinesEMBO Molecular Medicine, 2010
- A cellular implantation system using an injectable ultra‐purified alginate gel for repair of osteochondral defects in a rabbit modelJournal of Biomedical Materials Research Part A, 2010
- Alteration of angiogenic patterns on B16BL6 melanoma development promoted in MatrigelMedical Molecular Morphology, 2010
- Targeting Liver FibrosisHepatology, 2009
- Liver cirrhosisThe Lancet, 2008
- Leucine stimulates HGF production by hepatic stellate cells through mTOR pathwayBiochemical and Biophysical Research Communications, 2007
- Availability of bone marrow stromal cells in three-dimensional coculture with hepatocytes and transplantation into liver-damaged miceJournal of Bioscience and Bioengineering, 2005
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences, 1988